CAPR
CAPR
NASDAQ · Biotechnology

Capricor Therapeutics Inc

$29.10
-2.07 (-6.64%)
As of Mar 22, 10:09 PM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 15 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +114.6% upside
Low Target $34.96
Average Target $62.44
High Target $82.04
Current Price $29.10
Current
$29.10
Target
$62.44
$34.96 $62.44 avg $82.04
Scenario Analysis
Bear Case
$34.96
20.1%
Low target
Base Case
$62.44
+114.6%
Avg target
Bull Case
$82.04
+181.9%
High target
Risk/Reward
9.0x
Highly favorable
Price in Context
52-Week High
$40.37
-27.9% from high
52-Week Low
$4.30
+576.7% from low
Target vs 52W High
$62.44
+54.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%